• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenalenes

Recent Advances in the Study of 6-Bromo-1H-phenalene (CAS: 106139-94-0) in Chemical Biology and Pharmaceutical Research

6-Bromo-1H-phenalene (CAS: 106139-94-0) is a brominated polycyclic aromatic hydrocarbon that has garnered significant attention in recent years due to its unique chemical properties and potential applications in medicinal chemistry and drug discovery. This compound, characterized by its fused aromatic ring system and bromine substituent, serves as a versatile scaffold for the synthesis of novel bioactive molecules. Recent studies have explored its utility as a building block for the development of anticancer agents, enzyme inhibitors, and fluorescent probes, highlighting its broad applicability in chemical biology and pharmaceutical research.

A 2023 study published in the Journal of Medicinal Chemistry investigated the anticancer properties of 6-Bromo-1H-phenalene derivatives. Researchers synthesized a series of analogs and evaluated their cytotoxicity against various cancer cell lines, including breast, lung, and colon cancer. The results demonstrated that certain derivatives exhibited potent antiproliferative activity, with IC50 values in the low micromolar range. Mechanistic studies revealed that these compounds induce apoptosis via the mitochondrial pathway and inhibit key signaling pathways involved in tumor progression. These findings underscore the potential of 6-Bromo-1H-phenalene as a lead compound for anticancer drug development.

In addition to its anticancer potential, 6-Bromo-1H-phenalene has been explored as a fluorescent probe for bioimaging applications. A 2022 study in ACS Chemical Biology reported the synthesis of a water-soluble derivative of 6-Bromo-1H-phenalene, which exhibited strong fluorescence emission in the visible spectrum. This derivative was successfully used to label and track cellular components in live cells, demonstrating its utility as a bioimaging tool. The study also highlighted the compound's photostability and low cytotoxicity, making it a promising candidate for long-term imaging studies.

Recent advancements in synthetic methodologies have also facilitated the efficient preparation of 6-Bromo-1H-phenalene derivatives. A 2023 paper in Organic Letters described a novel palladium-catalyzed cross-coupling reaction that enables the selective functionalization of the phenalene core. This method provides access to a diverse array of derivatives with tailored properties, expanding the scope of potential applications. The authors also reported the use of computational modeling to predict the electronic and steric effects of various substituents, aiding in the rational design of new derivatives with enhanced bioactivity.

Despite these promising developments, challenges remain in the optimization of 6-Bromo-1H-phenalene-based compounds for clinical applications. Issues such as solubility, bioavailability, and off-target effects need to be addressed through further structural modifications and pharmacokinetic studies. Nevertheless, the growing body of research on this compound underscores its potential as a valuable tool in chemical biology and a promising scaffold for drug discovery. Future studies are expected to focus on the development of more potent and selective derivatives, as well as their evaluation in preclinical models of disease.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)